UnitedHealth Group (NYSE:UNH) Trading 1.5% Higher – Here’s What Happened

UnitedHealth Group Incorporated (NYSE:UNH)’s share price traded up 1.5% on Monday . The company traded as high as $283.30 and last traded at $281.4640. 5,890,940 shares traded hands during mid-day trading, a decline of 39% from the average session volume of 9,624,309 shares. The stock had previously closed at $277.26.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Raymond James upgraded UNH ahead of the Q1 print, signaling increased analyst conviction that management can show stabilization or progress next week. Raymond James Boosts UnitedHealth (UNH) Rating Before Q1 Results
• Positive Sentiment: High-profile investor interest: coverage noting billionaire Ken Griffin’s sizable exposure to UNH reinforces institutional confidence and may support demand for the shares. Is UnitedHealth Group (UNH) The Best Healthcare Stock to Buy According to Billionaire Ken Griffin?
• Positive Sentiment: Several bullish takes argue UNH’s pullback has priced in risks and that its Medicare Advantage franchise and value-based care model give upside if margins recover. These narratives support the recovery trade into earnings. UnitedHealth: Why It’s Still Not Too Late To Buy The Turnaround
• Neutral Sentiment: Q1 earnings preview pieces highlight analyst support but note weak guidance is already a risk — the upcoming report is the key near-term catalyst that could swing sentiment either way. UnitedHealth Q1 Earnings Preview: What To Expect From Upcoming Report
• Neutral Sentiment: Outlets emphasize April 21 as a make-or-break quarter — investors are positioning for either validation of management’s recovery or renewed questions if results disappoint. Is April 21 When UnitedHealth Group Finally Sheds Its Problem Past?
• Neutral Sentiment: Macro/sector drivers: a report on expected new Medicare payment rates matters for UNH because ~35M beneficiaries are in Medicare Advantage — payment changes could materially affect revenue/margins but direction depends on the final rate. New Medicare Payment Rate Expected. Why It’s a Big Deal for Healthcare Stocks.
• Neutral Sentiment: Broad market strength (Dow higher) is providing a mild tailwind to stocks including UNH today. Stock Market Today: Dow Up As Oil Pops; Bank Play Eyes Entry After This ‘Trump Accounts’ Move (Live Coverage)
• Negative Sentiment: Near-term headwinds remain: commentary highlighting a ~22% decline over six months, softer quarterly results and below-trend guidance is keeping downside risk elevated if Q1 fails to show clear recovery. 2 Reasons to Watch UNH and 1 to Stay Cautious

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on UNH. Barclays cut their price target on UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating on the stock in a research note on Friday, January 30th. Royal Bank Of Canada cut their target price on shares of UnitedHealth Group from $408.00 to $361.00 and set an “outperform” rating on the stock in a research report on Wednesday, January 28th. Wells Fargo & Company dropped their price target on shares of UnitedHealth Group from $400.00 to $370.00 and set an “overweight” rating for the company in a research note on Friday, January 30th. Jefferies Financial Group reduced their price objective on shares of UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating on the stock in a research note on Wednesday, January 28th. Finally, KeyCorp reaffirmed an “overweight” rating on shares of UnitedHealth Group in a report on Wednesday, January 28th. One research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $363.38.

UnitedHealth Group Price Performance

The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.72. The firm has a market cap of $255.48 billion, a P/E ratio of 21.34, a P/E/G ratio of 1.28 and a beta of 0.40. The business’s 50 day moving average is $283.03 and its two-hundred day moving average is $319.62.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, topping the consensus estimate of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The firm had revenue of $113.73 billion during the quarter, compared to analyst estimates of $113.38 billion. During the same period last year, the company posted $6.81 EPS. The business’s quarterly revenue was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were given a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, March 9th. This represents a $8.84 annualized dividend and a dividend yield of 3.1%. UnitedHealth Group’s dividend payout ratio (DPR) is 67.02%.

Institutional Trading of UnitedHealth Group

Several hedge funds have recently bought and sold shares of UNH. Vanguard Group Inc. grew its holdings in shares of UnitedHealth Group by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 91,600,260 shares of the healthcare conglomerate’s stock valued at $30,238,162,000 after buying an additional 995,210 shares during the last quarter. State Street Corp boosted its stake in UnitedHealth Group by 2.5% during the 4th quarter. State Street Corp now owns 45,232,170 shares of the healthcare conglomerate’s stock valued at $14,931,592,000 after purchasing an additional 1,119,834 shares during the last quarter. Capital World Investors raised its stake in shares of UnitedHealth Group by 3.8% in the fourth quarter. Capital World Investors now owns 22,591,042 shares of the healthcare conglomerate’s stock worth $7,457,723,000 after purchasing an additional 824,120 shares during the last quarter. Price T Rowe Associates Inc. MD grew its holdings in UnitedHealth Group by 3.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 18,829,054 shares of the healthcare conglomerate’s stock worth $6,215,660,000 after buying an additional 680,077 shares in the last quarter. Finally, Capital International Investors lifted its stake in UnitedHealth Group by 6.6% during the 4th quarter. Capital International Investors now owns 18,655,111 shares of the healthcare conglomerate’s stock valued at $6,158,734,000 after acquiring an additional 1,155,162 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.